Your browser doesn't support javascript.
loading
Exposure to TNF antagonist therapies induces variations of the gut microbiota in an in vivo model using healthy mice.
Gabay, Odile; Vicenty, Jonathan; Zack-Taylor, Autumn; Tiffany, Linda; Wunderlin, Grant; Smith, Dylan; Reyes-Munoz, Lismari; Edwards, Vivienne; Wu, Wells W; Phue, Je-Nie; Santana-Quintero, Luis; Lam, Phuc VinhNguyen; Clouse, Kathleen A.
Afiliação
  • Gabay O; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Division of Biotechnology Review and Research 1, Silver Spring, MD, USA. Electronic address: Odile.Engel@fda.hhs.gov.
  • Vicenty J; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Division of Biotechnology Review and Research 1, Silver Spring, MD, USA.
  • Zack-Taylor A; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Division of Biotechnology Review and Research 1, Silver Spring, MD, USA.
  • Tiffany L; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Division of Biotechnology Review and Research 1, Silver Spring, MD, USA.
  • Wunderlin G; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Division of Biotechnology Review and Research 1, Silver Spring, MD, USA.
  • Smith D; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Division of Biotechnology Review and Research 1, Silver Spring, MD, USA.
  • Reyes-Munoz L; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Division of Biotechnology Review and Research 1, Silver Spring, MD, USA.
  • Edwards V; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Division of Biotechnology Review and Research 1, Silver Spring, MD, USA.
  • Wu WW; U.S. Food and Drug Administration, Center for Biologicals Evaluation and Research, Facility for Biotechnology Resources, Silver Spring, MD, USA.
  • Phue JN; U.S. Food and Drug Administration, Center for Biologicals Evaluation and Research, Facility for Biotechnology Resources, Silver Spring, MD, USA.
  • Santana-Quintero L; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Hematology and Oncology Products, Silver Spring, MD, USA.
  • Lam PV; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Office of Biostatistics and Epidemiology, HIVE, Silver Spring, MD, USA.
  • Clouse KA; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Division of Biotechnology Review and Research 1, Silver Spring, MD, USA.
Joint Bone Spine ; 87(2): 175-178, 2020 03.
Article em En | MEDLINE | ID: mdl-31513888
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Microbioma Gastrointestinal / Inibidores do Fator de Necrose Tumoral Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Microbioma Gastrointestinal / Inibidores do Fator de Necrose Tumoral Idioma: En Ano de publicação: 2020 Tipo de documento: Article